Rapid Micro Biosystems scores $60 mln

Rapid Micro Biosystems, a provider of rapid microbial detection technology for the healthcare product manufacturing sector, has secured $60 million in financing. Bain Capital Life Sciences and Xeraya Capital led the round with participation from Asahi Kasei Medical, Longitude Capital, Quaker Partners, TVM Capital and Richard K. Mellon and Sons. Locust Walk provided financial advice to Rapid Micro Biosystems on the transaction.

Source: Press Release